1Colucci WS,Packer M,Bristow MR,et al.Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure[].Circulation.1996
2Bristow MR,Gilbert EM,Abraham WT,et al.Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure[].Circulation.1996
3Whorlow SL,Krum H.Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure[].The American Journal of Cardiology.2000
4Teerlink JR,Massie BM.Beta-adrenergic blocker mortality trials in congestive heart failure[].The American Journal of Cardiology.1999
5Waagestein F,Bristow MR,Swedberg K,et al.Beneficial effect of metoprolol in idiopathic dilated cardiomyopathy[].The Lancet.1993
6The Beta-Blocker Evaluation of Survival Trial Investigators.A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure[].The New England Journal of Medicine.2001
7CIBIS Investigators and Committees.A randomized trial ofβ-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study ( CIBIS )[].Circulation.1994
8Packer M,Coats AJS,Fowler MB,et al.Effect of carvedilol on survival in severe chronic heart failure[].The New England Journal of Medicine.2001
9CIBIS-II Investigators and Committees.The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial[].The Lancet.1999
10Packer M,Colucci WS,Sackner-Bernstein JD,et al.Double-blind,placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure.The PRECISE Trial[].Circulation.1996
